FindTrial
Sign In

STUDY ON PAIN RELIEF BY GABAPENTIN AND PREGABALIN IN THE PATIENT COMPLAINING PAIN DUE TO CHEMOTHERAPY

A Descriptive Study on Pain Relief by Gabapentin or Pregabalin in the Patients of Chemotherapy Induced Peripheral Neuropathy in the Outpatient Department of Radiation Oncology, SMS Hospital, Jaipur (Rajasthan) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062820
Enrollment
100
Registered
2024-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G63- Polyneuropathy in diseases classified elsewhere

Interventions

Intervention1: NILL: NILL

Sponsors

nill
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adult patients of both the sex. 2.Diagnosed cases of CIPN. 3.Completion of at least one cycle of chemotherapy irrespective of the type of cancer. 4.Patients willing to participate in the study. 5.Patients on Gabapentin or Pregabalin 6.All consecutive patients will be included

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women. 2.Non cooperative patients. 3.Patients participating in any other study.

Design outcomes

Primary

MeasureTime frame
pain scoreTimepoint: Change in pain will be assessed i.e. baseline 2nd week, 4th week and 8th week—

Secondary

MeasureTime frame
adverse events of Pregabalin & GabapentinTimepoint: adverse events will be assessed i.e. 2nd week, 4th week & 8th week—

Countries

India

Contacts

Public ContactDr Chandan Verma

Sawai Man Singh Medical College, Jaipur

chandanverma1970@gmail.com9414059213

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026